As interest in CAR T cells and immune-based oncology therapies increases, efficient phenotyping of cell therapy products ...

Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...

Northwestern Medicine scientists have identified the cellular mechanisms that cause immune cells to differentiate and ultimately lose function during viral infection, findings that could improve ...

Rapid developments in gene-modified cell therapies, especially CAR T-cell therapies, has increased demand for fast and reliable analytics methods for research, in-process development, and ...

A research team from George R Brown School of Engineering and Computing (Rice University; TX, USA), led by Peter Lillehoj and Kevin Mchugh, have developed an innovative AI-enabled microfluidic ...

Detailed mapping of CD4⁺ T cells from children with systemic lupus erythematosus (SLE) has revealed distinct immune cell subsets with likely roles in disease pathogenesis, according to a study led by ...

Abnormal expansion of PD-1+ T lymphocytes may be a sign of lupus nephritis onset in patients with SLE. Elevated PD-1+CD4+ T cells represent an independent risk factor for lupus nephritis (LN) and may ...

Comprehensive digital guide to high-throughput screening (HTS) by cytometry, featuring assays, application data, and more Introduction to HTS cytometry and the all-in-one software solution for data ...